Lung Cancer
Conditions
Interventions
Sponsors
The Second Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age =60 years; pathologically or cytologically confirmed lung cancer; receipt of at least one cycle of immunotherapy, with documented information on drug administration and treatment regimen. Baseline data were also required, including imaging examinations (chest CT and/or PET-CT), baseline complete blood count, liver and renal function tests, inflammatory markers, and records of baseline pulmonary comorbidities (such as COPD or interstitial lung disease) and prior radiotherapy history.
Exclusion criteria
Exclusion criteria: 1.Patients with active pneumonia or an acute exacerbation of interstitial lung disease before immunotherapy;patients in whom CIP could not be reliably determined based on imaging or clinical data;patients with organ transplantation, uncontrolled HIV infection, long-term intensive immunosuppressive therapy, or a history of autoimmune disease;and patients with incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of immune-related pneumonitis;Accuracy;Sensitivity; | — |
Countries
China
Contacts
Public ContactSubo Gong
The Second Xiangya Hospital of Central South University
Outcome results
None listed